Dual biological functions of an interleukin‐1 receptor antagonist–interleukin‐10 fusion protein and its suppressive effects on joint inflammation

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Immunology

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2567.2004.01910.xPMID 15270736PMCID PMC1782518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation

  2008cited by this paper
• Regulatory Role of Interleukin-10 in Experimental Group B Streptococcal Arthritis

  2002cited by this paper
• The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.

  2001cited by this paper
• Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium

  2001cited by this paper
• Viral IL-10 and Soluble TNF Receptor Act Synergistically to Inhibit Collagen-Induced Arthritis Following Adenovirus- Mediated Gene Transfer1

  2000cited by this paper
• Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.

  2000cited by this paper
• IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells.

  1999cited by this paper
• IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis.

  1998cited by this paper
• Interleukin-1 receptor antagonist: role in biology.

  1998cited by this paper
• Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

  1998cited by this paper
• Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy.

  1998cited by this paper
• IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis.

  1998cited by this paper
• Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.

  1998cited by this paper
• Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritis.

  1998cited by this paper
• Pro- and anti-inflammatory cytokines in rheumatoid arthritis.

  1997cited by this paper
• T cell signaling of macrophage function in inflammatory disease.

  1997cited by this paper
• Human Th1 cells preferentially induce interleukin (IL)‐1β while Th2 cells induce IL‐1 receptor antagonist production upon cell/cell contact with monocytes

  1997cited by this paper
• Synovial tissue macrophage populations and articular damage in rheumatoid arthritis.

  1996cited by this paper
• The production and characterization of a modified recombinant interleukin-1 receptor antagonist.

  1996cited by this paper
• Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group.

  1996cited by this paper
• Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4.

  1996cited by this paper
• Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis.

  1996cited by this paper
• Measurement of Mouse and Human Interleukin 9

  1996cited by this paper
• Immunosuppressive and anti-inflammatory properties of interleukin 10.

  1995cited by this paper
• Interleukin-1 reversibly inhibits the synthesis of biglycan and decorin in intact articular cartilage in culture.

  1995cited by this paper
• Interleukin-1 reversibly inhibits the synthesis of biglycan and decorin in intact articular cartilage in culture.

  1995cited by this paper
• Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis.

  1994cited by this paper
• Modulation of cytokine function: therapeutic applications.

  1994cited by this paper
• Interleukin-10.

  1993cited by this paper
• Cytokines in health and disease.

  1993cited by this paper
• Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.

  1993cited by this paper
• Reduction of monocyte‐macrophage activation markers upon anti‐CD4 treatment. Decreased levels of IL‐1, IL‐6, neopterin and soluble CD14 in patients with rheumatoid arthritis

  1993cited by this paper
• IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium.

  1992cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992cited by this paper
• Current protocols in immunology

  1991cited by this paper
• Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist.

  1991cited by this paper
• Quantitative analysis of cytokine gene expression in rheumatoid arthritis.

  1990cited by this paper
• Rheumatoid arthritis. Pathophysiology and implications for therapy.

  1990cited by this paper
• Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

  1990cited by this paper
• Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

  1988cited by this paper
• Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

  1986cited by this paper
• Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).

  1986cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION

  1981cited by this paper

• Surf4 collaborates with Derlin-2 and Derlin-1 to mediate Cyclooxygenase-2 translocation to the cytosol for degradation.

  2023cites this paper
• Relative Expression of OX40, OX40L mRNA, and OX40L Serum Levels in Women with Recurrent Spontaneous Abortion

  2019cites this paper
• Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.

  2014cites this paper
• A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis.

  2012cites this paper
• 1 receptor type I agonist of chimeric IL and antagonist

  2011cites this paper
• The anti‐inflammatory modulatory role of Solidago chilensis Meyen in the murine model of the air pouch

  2008cites this paper
• Cytokine and clinical predictors for treatment outcome of visually guided temporomandibular joint irrigation in patients with chronic closed lock.

  2008cites this paper
• Estudo do efeito antiinflamatório da Solidago chilensis Meyen em modelo de inflamação induzida pela carragenina, em camundongos

  2007cites this paper
• Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.

  2006cites this paper
• Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes.

  2005cites this paper